Viz.ai and UTMB Announce Collaboration to Accelerate Recruitment in the CHESS Study with Viz Subdural Solution
In the CHESS trial, Viz.ai will notify investigators immediately when it detects a patient who has suspected SDH and meets the eligibility criteria for enrollment.
- In the CHESS trial, Viz.ai will notify investigators immediately when it detects a patient who has suspected SDH and meets the eligibility criteria for enrollment.
- Study investigators can measure chronic bleeds4 and coordinate subject enrollment easily and securely through Viz.ai’s dynamic, mobile, HIPAA-compliant platform.
- Management of chronic subdural hematoma with the subdural evacuating port system: Systematic review and meta-analysis.
- https://pubmed.ncbi.nlm.nih.gov/33775320/
4 Viz Subdural is currently available commercially for triage and notification.